期刊文献+

加用氟西丁对氯氮平血浓度及临床效应的影响 被引量:1

下载PDF
导出
摘要 目的观察加用氟西丁12个月对氯氮平血浓度及临床效应的影响。方法入组病例随机分成2组,1组在原来氯氮平治疗的基础上加用氟西丁20mg/d,1组单用氯氮平,治疗12个月,于入组前、入组后第3月、6月、12月末评定PANSS、TESS、测定氯氮平血浓度。结果加用氟西丁组阳性症状、阴性症状在第3月、6月、12月均明显下降(P<0.05),阳性症状、阴性症状有效率高于对照组,但与对照组比较均无统计差异(P>0.05)。加用氟西丁组在第3月、6月、12月氯氮平血浓度、TESS总分均明显升高(P<0.01)。结论加用氟西丁不能明显增加慢性精神分裂症的疗效,但可增加有效机率;会导致氯氮平血浓度升高,增加不良反应。
出处 《神经疾病与精神卫生》 2007年第1期43-45,共3页 Journal of Neuroscience and Mental Health
  • 相关文献

参考文献6

  • 1Golf D C,Brotman A W,Waitrs M,et al.Trial of fluoxtine addrd to neuroleptics for treatment-resistant schizophrenic patients[J].Am J Psychiatry,1990,147(4):492.
  • 2Goldman M B,Janecek H M.Adjunctive fluoxtine improves global function in chronic schizophrenia[J].J Neuropsychiatry,1990,2:429.
  • 3Buchaman R W,Kirkpatrick B,Byyant N,et al.fluoxtine augmentation of clozapine treatment in patients with schizophrenia[J].Am J Psychiatry,1996,153(12):1 625.
  • 4王立伟,王志阳,诸索宇,李华芳,毛月萌.加用氟西汀对氯氮平疗效及血浓度的影响[J].上海精神医学,2000,12(2):66-68. 被引量:9
  • 5王定省,高哲石,沈阿珍,何怡发,吴国君,谢帆.氟西汀合并抗精神病药物治疗精神分裂症阴性症状的研究[J].上海精神医学,2000,12(4):208-210. 被引量:28
  • 6Golf D C,Midha K K,Sarid-Segal O,et al.A placebo controlled trial of fluoxtine added to neuroleptic in patients with schizophrenia[J].Psychopharmacology(Berl),1995,117:417.

二级参考文献12

  • 1[1]Goff D C,Brotman A W,Waites M,et al.Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients.Am J Psychiatry,1990,147(4):492
  • 2[2]Goldman M B,Janecek H M.Adjunctive fluoxetine improves global function in chronic schizophrenia.J Neuropsychiatry,1990,2:429
  • 3[3]Goff D C,Midha K K,Sarid-Segal O,et al.A placebo controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia.Psychopharmacology (Berl),1995,117:417
  • 4[4]Buchanan R W,Kirkpatrick B,Bryant N,et al.Fluoxetine augmentation of clozapine treatment in patients with schizophrenia.Am J Psychiatry,1996,153(12):1625
  • 5[5]Spina E,Avenoso A,Facciol G,et al.Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenia.Int Clin Psychopharmacol,1998,13(3):141
  • 6[6]Centorrino F,Baldessarini R J,Frankenburg F R,et al.Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors.Am J Psychiatry,1996,153(6):820
  • 7[7]Gentorrino F,Baldessarini R J,Kando J,et al.Serum concentrations of clozapine and its major metabolites:effects of cotreatment with fluoxetine or valproate.Am J Psychiatry,1994,151(1):123
  • 8[1]Thakore J M,Berti C,Dinan T G.An open trial of adjunctive sertraline in the theatment of chronic schizophrenis.Acta Psychiatry Scand,1996,94:194~197
  • 9[2]Doldman M B,Janecek H M.Adjunetive fluoxetine improves global function in chronic schizofrenia.J Neuropsyehiatry,1990,2:429~431
  • 10[3]Doff D C,Brotman A W,Waites M,et al.Trial of fluoetine added to neuroleptic for treatment-resistant schizophrenic patients.Am J Psychiatry,1990,147:492~494

共引文献34

同被引文献26

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部